{"id":10417,"date":"2025-04-09T07:19:58","date_gmt":"2025-04-09T07:19:58","guid":{"rendered":"https:\/\/ambercell.eu\/?page_id=10417"},"modified":"2026-11-12T13:35:55","modified_gmt":"2026-11-12T11:35:55","slug":"selective-intra-arterial-radio-therapy-sirt-2","status":"publish","type":"page","link":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/","title":{"rendered":"Percutaneous Coronary Intervention (CTO PCI)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"10417\" class=\"elementor elementor-10417 elementor-10416\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-55dcfde e-flex e-con-boxed e-con e-parent\" data-id=\"55dcfde\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0829351 e-con-full e-flex e-con e-child\" data-id=\"0829351\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-e9e7c1a e-flex e-con-boxed e-con e-child\" data-id=\"e9e7c1a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-d171ab2 e-flex e-con-boxed e-con e-child\" data-id=\"d171ab2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a7f68e9 elementor-widget elementor-widget-spacer\" data-id=\"a7f68e9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a52c32b elementor-widget elementor-widget-text-editor\" data-id=\"a52c32b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"79\" data-end=\"1198\">Chronic total occlusion (Eng. <strong data-start=\"111\" data-end=\"138\">Chronic Total Occlusion<\/strong>, CTO is one of the most complex and clinically significant areas of coronary intervention. CTO occurs when the coronary artery is completely blocked for at least three months and no blood reaches the affected part of the heart. Due to impaired blood flow, the heart does not receive enough oxygen and nutrients, which leads to the symptoms of angina pectoris. CTO is found in up to 30% of patients with coronary artery disease <strong>[1].<\/strong> CTO cases have long been considered technically complex and hard-to-treat invasive methods, but in recent years, advances in percutaneous methods and specialized equipment have improved treatment outcomes for this condition. Procedural risks associated with CTO percutaneous coronary intervention (PCI) in experienced centers are steadily decreasing <strong>[0].<\/strong> The latest advances in interventional cardiology and new CTO treatment strategies enable excellent outcomes, improving patient survival and quality of life. The latest data from US CTO treatment centers show that CTO PCI technical success rates exceed 90% <strong>[20]<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-039908a elementor-widget elementor-widget-image\" data-id=\"039908a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"529\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1.webp\" class=\"attachment-large size-large wp-image-10583\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1.webp 893w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1-300x198.webp 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/The-components-of-chronic-total-occlusion-CTO-lesions-1-768x507.webp 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">CTO Warehouse Components [30]<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-46fae75f e-flex e-con-boxed e-con e-parent\" data-id=\"46fae75f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-5a746995 e-con-full e-flex e-con e-child\" data-id=\"5a746995\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4c9d82fd elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"4c9d82fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-739014d e-flex e-con-boxed e-con e-child\" data-id=\"739014d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2dff45c8 elementor-hidden-mobile e-flex e-con-boxed e-con e-child\" data-id=\"2dff45c8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-72aae63c elementor-widget elementor-widget-heading\" data-id=\"72aae63c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">What is a PCI CTO?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-106d61f7 e-flex e-con-boxed e-con e-child\" data-id=\"106d61f7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-396b6b44 elementor-widget elementor-widget-text-editor\" data-id=\"396b6b44\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>For a long time, patients with CTO conditions experiencing angina (chest pain, shortness of breath, fatigue) required open-heart surgery \u2013 coronary artery bypass surgery (CABG). Today, CTO can be treated using a minimally invasive method called <strong>percutaneous coronary intervention (PCI).<\/strong> This procedure involves opening the artery using balloons, stents, and specialized equipment. With advances in CTO PCI methods, equipment, and increasing procedural experience, CTO PCI is now regarded as a predictable and effective treatment method. European physician guidelines on myocardial revascularization recommend performing CTO PCI to reduce ischemia in the affected myocardial area and alleviate angina symptoms <strong>[2].<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-58aba326 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"58aba326\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8122074 e-flex e-con-boxed e-con e-parent\" data-id=\"8122074\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-5bc5ab0 e-con-full e-flex e-con e-child\" data-id=\"5bc5ab0\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2952f5e elementor-widget elementor-widget-heading\" data-id=\"2952f5e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Patient selection<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fb2d651 elementor-widget elementor-widget-text-editor\" data-id=\"fb2d651\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"0\" data-end=\"219\">Using modern methods and equipment, patient selection should be based not only on determining the level of lesion (complete, partial, or severe) but also on symptoms and diagnostic outcomes <strong>[3].<\/strong><\/p>\n<p class=\"\" data-start=\"221\" data-end=\"302\">Currently, by expert consensus, four main CTO PCI indications are distinguished:<\/p>\n<ul data-start=\"304\" data-end=\"734\" data-is-last-node=\"\" data-is-only-node=\"\">\n<li class=\"\" data-start=\"304\" data-end=\"401\">\n<p class=\"\" data-start=\"306\" data-end=\"401\">Relief of symptoms limiting quality of life and improvement of physical exercise tolerance.<\/p>\n<\/li>\n<li class=\"\" data-start=\"402\" data-end=\"469\">\n<p class=\"\" data-start=\"404\" data-end=\"469\">Reduction of ischemic burden achieved through non-invasive tests.<\/p>\n<\/li>\n<li class=\"\" data-start=\"470\" data-end=\"583\">\n<p class=\"\" data-start=\"472\" data-end=\"583\">Reduction of dyspnea associated with left ventricular (LV) dysfunction in the presence of evidence of viable myocardium.<\/p>\n<\/li>\n<li class=\"\" data-start=\"584\" data-end=\"734\">\n<p class=\"\" data-start=\"586\" data-end=\"734\">Improvement of long-term prognosis in patients with high-risk multiple vascular coronary artery disease (CAD) <strong>[23][24][25][26][27].<\/strong><\/p>\n<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8abc811 elementor-widget elementor-widget-text-editor\" data-id=\"8abc811\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-12\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"bca3f07c-3a98-4f6f-a39c-4f32418db4e0\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"380\">CTO is more common in elderly patients. Studies show that the prevalence of CTO is 36.5% of patients under 65 years old, 39.1% among patients aged 65\u201379, and 40.7% among patients over 80 years old<strong> [16].<\/strong> The most commonly affected blood vessels are the right coronary artery, followed by the left anterior descending artery and the left rotating artery.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d1a9f63 elementor-widget elementor-widget-image\" data-id=\"d1a9f63\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"486\" height=\"484\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1.jpg\" class=\"attachment-large size-large wp-image-10587\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1.jpg 486w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1-300x300.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/fcvm-11-1350549-g001-1-150x150.jpg 150w\" sizes=\"(max-width: 486px) 100vw, 486px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">CTO PCI Indications [29]<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d25e8dd elementor-widget elementor-widget-text-editor\" data-id=\"d25e8dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>For asymptomatic patients, ischemia should be evaluated by PCI before performing a CTO. The success of the procedure depends on whether the heart tissue can still recover. It is recommended to use comprehensive diagnostic methods such as transmural infarction assessment, contractile reserve evaluation with dobutamine, and cardiac MRI to evaluate normal myocardial wall thickening function<strong> [5].<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-20b82f8 e-flex e-con-boxed e-con e-parent\" data-id=\"20b82f8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-aeef9e4 e-con-full e-flex e-con e-child\" data-id=\"aeef9e4\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2e56834 elementor-widget elementor-widget-heading\" data-id=\"2e56834\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Procedure planning<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7d0fe7f elementor-widget elementor-widget-text-editor\" data-id=\"7d0fe7f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-18\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"1e85cd96-aaac-4115-90e5-abef1d3e770b\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"431\">Pre-procedural planning includes angiographic assessment to assess the likelihood of success and select the most appropriate intervention method. One of the most widely used tools is the <em>J-CTO<\/em> score. The hybrid algorithm improves success rates by reducing procedure duration, radiation dose, and contrast agent amount, as well as standardizing methodologies and reducing differences in operator work <strong>[11][12].<\/strong><\/p>\n<p class=\"\" data-start=\"433\" data-end=\"1247\">Using a standardized hybrid algorithm, treatment facilities in North America and Europe achieve success rates exceeding 90%. This method involves inserting two guiding catheters\u2014one into each coronary artery\u2014to perform a dual contrast injection and ensure a smooth transition between the antegrade and retrograde conduction methods. A double-contrast angiogram allows assessment of lesion characteristics such as length and anatomy of collateral circulation. Based on this data, doctors select the optimal guidance method during the procedure and monitor procedure parameters\u2014duration, irradiation, and contrast amount. This algorithm works even for high-risk patients who have undergone CABG surgery\u2014achieving an 87.5% success rate<strong> [11].<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f159a4d e-flex e-con-boxed e-con e-parent\" data-id=\"f159a4d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0ca71ba e-flex e-con-boxed e-con e-child\" data-id=\"0ca71ba\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0ba41a7 e-con-full e-flex e-con e-child\" data-id=\"0ba41a7\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6307d0c elementor-widget elementor-widget-heading\" data-id=\"6307d0c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Stages of the CTO procedure<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9e976be elementor-widget elementor-widget-text-editor\" data-id=\"9e976be\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-20\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"252eebdb-b10f-4779-aad3-129f7747e992\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"225\">The procedure is similar to cardiac catheterization. To justify a clear clinical indication, the patient must undergo a comprehensive examination before the procedure, including assessment of symptoms, ischemia, and myocardial viability<strong> [9].<\/strong><\/p>\n<p class=\"\" data-start=\"227\" data-end=\"258\">The main stages of the procedure:<\/p>\n<ul data-start=\"260\" data-end=\"779\" data-is-last-node=\"\" data-is-only-node=\"\">\n<li class=\"\" data-start=\"260\" data-end=\"354\">\n<p class=\"\" data-start=\"262\" data-end=\"354\"><strong data-start=\"262\" data-end=\"292\">Guiding catheter insertion<\/strong> \u2013 allows access to the CTO (chronic total occlusion) site.<\/p>\n<\/li>\n <li class=\"\" data-start=\"355\" data-end=\"446\">\n<p class=\"\" data-start=\"357\" data-end=\"446\"><strong data-start=\"357\" data-end=\"385\">Guidewire transfer<\/strong> \u2013 specialized CTO wires and microcatheters are used.<\/p>\n<\/li>\n <li class=\"\" data-start=\"447\" data-end=\"591\">\n<p class=\"\" data-start=\"449\" data-end=\"591\"><strong data-start=\"449\" data-end=\"496\">Disection and re-entry techniques<\/strong> \u2013 in complex cases, a retrograde method through collateral arteries can be applied.<\/p>\n<\/li>\n<li class=\"\" data-start=\"592\" data-end=\"682\">\n<p class=\"\" data-start=\"594\" data-end=\"682\"><strong data-start=\"594\" data-end=\"621\">Balloon angioplasty<\/strong> \u2013 when the guidewire is successfully inserted, the artery is widened.<\/p>\n<\/li>\n <li class=\"\" data-start=\"683\" data-end=\"779\">\n<p class=\"\" data-start=\"685\" data-end=\"779\"><strong data-start=\"685\" data-end=\"700\">Stenting<\/strong> \u2013 to ensure blood vessel patency and reduce the risk of restenosis.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd714c6 elementor-widget elementor-widget-heading\" data-id=\"cd714c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO PCI technique<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-795a6b3 elementor-widget elementor-widget-text-editor\" data-id=\"795a6b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-22\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[70rem]:[--thread-content-margin:--spacing(12)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"fc5c261e-2ef9-44f9-8836-823ebea78ecb\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\">\n<p class=\"\" data-start=\"0\" data-end=\"176\">CTO PCI requires technical skills and specialized equipment. Key techniques include:<\/p>\n<ul data-start=\"178\" data-end=\"675\">\n<li class=\"\" data-start=\"178\" data-end=\"308\">\n<p class=\"\" data-start=\"180\" data-end=\"308\"><strong data-start=\"180\" data-end=\"228\">Antegrade guide wire escalation (AWE):<\/strong> increasingly stiffer guide wires are used to penetrate the occlusion.<\/p>\n<\/li>\n<li class=\"\" data-start=\"309\" data-end=\"447\">\n<p class=\"\" data-start=\"311\" data-end=\"447\"><strong data-start=\"311\" data-end=\"366\">Antegrade dissection and reentry (ADR):<\/strong> a controlled subintimal dissection is performed to overcome the lesion.<\/p>\n<\/li>\n<li class=\"\" data-start=\"448\" data-end=\"589\">\n<p class=\"\" data-start=\"450\" data-end=\"589\"><strong data-start=\"450\" data-end=\"475\">Retrograde method<\/strong>: the lesion is accessed through the collateral arteries, usually applied when antegrade tests fail.<\/p>\n<\/li>\n<li class=\"\" data-start=\"590\" data-end=\"675\">\n<p class=\"\" data-start=\"592\" data-end=\"675\"><strong data-start=\"592\" data-end=\"614\">Hybrid method<\/strong>: combines several strategies to achieve optimal results.<\/p>\n<\/li>\n<\/ul>\n<p class=\"\" data-start=\"677\" data-end=\"966\">Recent studies show that the hybrid approach achieves 85-90% success <strong>[6][7][8],<\/strong> and over <strong>90%<\/strong> technical success in US CTO centers. Strictly adhering to the hybrid approach, success rates reach 93.4% for patients without previous CABG surgery and 88.1% for patients after CABG<strong> [20].<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-61ad97d elementor-widget elementor-widget-image\" data-id=\"61ad97d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"844\" height=\"743\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos.jpg\" class=\"attachment-full size-full wp-image-10596\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos.jpg 844w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos-300x264.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/technikos-768x676.jpg 768w\" sizes=\"(max-width: 844px) 100vw, 844px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-67f95df e-flex e-con-boxed e-con e-parent\" data-id=\"67f95df\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-d91a867 e-con-full e-flex e-con e-child\" data-id=\"d91a867\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c484acf elementor-widget elementor-widget-heading\" data-id=\"c484acf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Advantages of CTO PCI<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-19853e0 elementor-widget elementor-widget-text-editor\" data-id=\"19853e0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CTO PCI is a rapidly advancing field. Using appropriate equipment and modern techniques, large-scale and highly competent centers achieve high success rates. Successful CTO recanalization is associated with reduced angina intensity, improved quality of life, increased physical capacity, improved ventricular function, and reduced mortality.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fdaa572 elementor-widget elementor-widget-image\" data-id=\"fdaa572\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"359\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/lentele.webp\" class=\"attachment-large size-large wp-image-10600\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2ae3393 elementor-widget elementor-widget-image\" data-id=\"2ae3393\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"217\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-1024x278.jpg\" class=\"attachment-large size-large wp-image-10604\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-1024x278.jpg 1024w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-300x81.jpg 300w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates-768x208.jpg 768w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/studija-succes-rates.jpg 1040w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\">CTO PCI success rates by publications [26] <\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4798d76 elementor-widget elementor-widget-text-editor\" data-id=\"4798d76\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"83\" data-end=\"109\">The Italian CTO registry<\/strong> evaluated clinical outcomes of 1,777 patients and showed lower mortality (1.4%, 4.7%, and 6.3%, p &lt; 0.001) and a MACE incidence after one year (2.6%, 8.2%, and 6.9%, p &lt; 0.001) in patients treated with PCI compared to those treated conservatively or surgically. In this study, the patient group receiving optimized medication experienced higher rates of MACE, mortality, and rehospitalizations <strong>[13].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"547\" data-end=\"566\">Sapontis et al.<\/strong> evaluated the quality of life of 1,000 patients undergoing OCT PCI. After one month of follow-up, significant improvements were observed in all <strong data-start=\"692\" data-end=\"737\">Seattle angina scores (SAQ),<\/strong> <strong data-start=\"739\" data-end=\"762\">Rose dyspnea scale<\/strong> , and <strong data-start=\"766\" data-end=\"775\">PHQ-8<\/strong> areas <strong>[14].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"802\" data-end=\"816\">In Japan<\/strong>, 904 series of consecutive PCI procedures for CTO were performed between 2002 and 2008 (Rathore et al., 2009). Technical success was achieved in 87.5% of cases, and procedural success (technical success without MACE) in 86.2%. The use of various conductor routing techniques increased annually (parallel conductors, retrograde routing, intravascular ultrasound, CART method). Within the hospital, the MACE incidence was 1.5% in patients with successful CTO PCI, and slightly higher \u2013 4.4% \u2013 in the unsuccessful procedure group (p = 0.027) <strong>[21].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"1349\" data-end=\"1378\">The latest meta-analysis<\/strong>, covering 9 studies and more than 6,400 patients, compared long-term clinical outcomes between patients who had successful CTO recanalization and those who were not. According to this study, in successful recanalization, the risk of death, MI, and MACE was approximately <strong data-start=\"1656\" data-end=\"1672\">50% lower<\/strong>, and the <strong data-start=\"1676\" data-end=\"1735\">rate of myocardial revascularization was up to 90% lower<\/strong> <strong>[15].<\/strong><\/li>\n<li data-start=\"83\" data-end=\"545\"><strong data-start=\"1743\" data-end=\"1778\">The EuroCTO multicenter study<\/strong> (&#8220;Randomized multicenter trial evaluating the application of revascularization or optimal drug therapy for chronic complete cases of coronary artery occlusion&#8221;) randomly assigned 396 patients to either CTO-PCI or optimal drug therapy (OMT) groups. After 12 months, compared to patients treated solely for drug therapy, the CTO-PCI group showed a greater reduction in angina frequency (subscale change difference \u2013 5.23; 95% CI: 1.75\u20138.71; p = 0.003) and improvement in quality of life (subscale change difference \u2013 6.62; 95% CI: 1.78\u201311.46; p = 0.007), assessed according to the <strong data-start=\"2434\" data-end=\"2473\">Seattle angina<\/strong> questionnaire <strong>[22].<\/strong> Patients with successful CTO PCI experienced fewer physical restrictions, fewer angina symptoms, better mobility, and increased physical activity compared to those treated with OMT alone. A low risk of complications was also recorded during procedures, and the <strong data-start=\"2733\" data-end=\"2796\">12-month MACE rate was similar to that of the OMT group<\/strong> <strong>[28].<\/strong><\/li>\n<\/ul>\n<p><strong><strong>  <\/strong><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7eae72e elementor-widget elementor-widget-heading\" data-id=\"7eae72e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CTO PCI success rates and forecast<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3fa96f6 elementor-widget elementor-widget-text-editor\" data-id=\"3fa96f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul>\n<li>\n<p class=\"\" data-start=\"52\" data-end=\"347\">The<strong data-start=\"52\" data-end=\"111\"> success rates <\/strong>of CTO-PCI procedures are determined by improved tools, more advanced microcatheters, and advanced imaging technologies. Currently, in specialized centers staffed by experienced procedure operators, success rates exceed 85\u201390%. Several key factors determine the success of procedures:<\/p>\n<ul data-start=\"349\" data-end=\"821\">\n<li class=\"\" data-start=\"349\" data-end=\"467\">\n<p class=\"\" data-start=\"351\" data-end=\"467\"><strong data-start=\"351\" data-end=\"371\">Patient selection<\/strong>: Favorable anatomy and a well-developed collateral circulatory network improve outcomes.<\/p>\n<\/li>\n <li class=\"\" data-start=\"468\" data-end=\"609\">\n<p class=\"\" data-start=\"470\" data-end=\"609\"><strong data-start=\"470\" data-end=\"495\">Physician experience<\/strong>: Experienced interventional specialists using advanced techniques can manage complex cases more effectively.<\/p>\n<\/li>\n <li class=\"\" data-start=\"610\" data-end=\"821\">\n<p class=\"\" data-start=\"612\" data-end=\"821\"><strong data-start=\"612\" data-end=\"646\">Advanced imaging support<\/strong>: Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) help optimize stent positioning and direct it with exceptional precision.<\/p>\n<\/li>\n<\/ul>\n<p class=\"\" data-start=\"823\" data-end=\"1001\"><strong data-start=\"823\" data-end=\"878\">The long-term prognosis after a successful CTO-PCI is favorable<\/strong> \u2013 in properly selected patients, angina symptoms significantly decrease and left ventricular function improves.<\/p>\n<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fe9fdee elementor-widget elementor-widget-heading\" data-id=\"fe9fdee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Conclusions<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bd0d594 elementor-widget elementor-widget-text-editor\" data-id=\"bd0d594\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\" data-start=\"57\" data-end=\"736\">The <strong data-start=\"57\" data-end=\"205\">CTO PCI procedure is rapidly gaining popularity in modern interventional cardiology<\/strong> and fundamentally changing complex coronary artery disease treatment strategies. Although historically this procedure was rarely used \u2013 accounting for only about 5% of all PCI procedures worldwide<strong> [10]<\/strong> and attempted in only 10\u201315% of cases <strong>[16][17][18]<\/strong> \u2013 technological progress and the growing experience of procedure operators are leading to a paradigm shift \u2013 today, CTO PCI success rates have significantly increased, while the frequency of complications has sharply decreased. For example, Patel et al. found that the frequency of severe complications decreased from 1.6% (2000\u20132002) to just 0.5% (2009\u20132011)<strong> [19].<\/strong><\/p><p class=\"\" data-start=\"738\" data-end=\"1236\"><strong data-start=\"738\" data-end=\"853\">Randomized clinical trials confirm the main advantage of CTO-PCI \u2013 better symptom relief.<\/strong> Moreover, ongoing innovations allow treatment of previously considered &#8220;incurable&#8221; vascular lesion sites by making them suitable for revascularization procedures <strong>[29].<\/strong> Compared to optimal drug treatment (OMT), CTO-PCI provides significant benefits to patients: reduced physical limitations, fewer angina symptoms, improved mobility, and increased physical activity.<\/p> <p class=\"\" data-start=\"1238\" data-end=\"1622\"><strong data-start=\"1238\" data-end=\"1382\">With advances in imaging tools, catheter technologies, and procedure techniques, success rates of CTO-PCI procedures are expected to continue growing. <\/strong> For doctors working with CTO patients, an individualized, patient-centered approach remains extremely important \u2013 using the latest technologies and clinical evidence to achieve the best outcomes and a higher quality of life.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-944e0fd elementor-widget elementor-widget-heading\" data-id=\"944e0fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Case studies<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2ee30af elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"2ee30af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/Copy-of-CTO-PCI-atvejo-analize-1z.pdf\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"544\" height=\"762\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis.jpg\" class=\"attachment-large size-large wp-image-11461\" alt=\"\" srcset=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis.jpg 544w, https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/cto-case-study-paveikslelis-214x300.jpg 214w\" sizes=\"(max-width: 544px) 100vw, 544px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f6de531 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"f6de531\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/Copy-of-CTO-Kalnins-Case-study-LT-3.pdf\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"558\" height=\"789\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/06\/case-study-kanins.webp\" class=\"attachment-large size-large wp-image-11469\" alt=\"\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9d13e39 e-flex e-con-boxed e-con e-parent\" data-id=\"9d13e39\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ac525b2 elementor-widget__width-auto elementor-widget elementor-widget-text-editor\" data-id=\"ac525b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>Sources: <\/em><\/p>\n<p><em><strong>[0]<\/strong> Christian O. Koelbl, Zoran S. Nedeljkovic2 and Alice K. Jacobs, Coronary Chronic Total Occlusion (CTO): A Review; Columbia University Division of Cardiology Mount Sinai Heart Institute 4300 Alton Road De Hirsch Meyer Tower Suite 2070 Miami Beach, FL 33140, USA<\/em><br><em><strong>[1]<\/strong> Jeroudi OM, Alomar ME, Michael TT, El Sabbagh A, Patel VG, Mogabgab O, et al. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv. 2014; 84(4):637-43.<\/em><br><em><strong>[2]<\/strong> Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al; Authors\/Task Force members. 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur, Heart, J., 2014; 35(37):2541-619.<\/em><br><em><strong>[3]<\/strong> Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association,  American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Lost Cardiol. 2017; 69(17):2212-41.<\/em><br><em><strong>[4]<\/strong> Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur, Heart, J., 2006; 27(20):2406-12.<\/em><br><em><strong>[5]<\/strong> &#8211; Kirschbaum SW, Rossi A, Boersma E, Springeling T, van de Ent M, Krestin GP, et al. Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention. You&#8217;re J Cardiol. 2012; 159(3):192-7.<\/em><br><em><strong>[6]<\/strong> Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016; 102(18):1486-93.<\/em><br><em><strong>[7]<\/strong> Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017; 10(15):1523-34.<\/em><br><em><strong>[8]<\/strong> Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. You&#8217;re J Cardiol. 2015; 198:222-8<\/em><\/p>\n<p><em><strong>[9]<\/strong>Nombela-Franco L, Urena M, Jerez-Valero M, et al. Validation of the J-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort. Circ Cardiovasc Interv 2013; 6(6):635\u2013643<\/em><br><em><strong>[10]<\/strong> &#8211; Guan C, Yang W, Song L, et al. Association of acute procedural results with long-term outcomes after CTO PCI. JACC Cardiovasc Interv 2021; 14(3):278\u201388.<\/em><br><em><strong>[11]<\/strong> Christakopoulos GE, Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, et al. Predictors of excess patient radiation exposure during chronic total occlusion coronary intervention: insights from a contemporary multicentre registry. Can J Cardiol. 2017; 33(4):478-84.<\/em><br><em><strong>[12]<\/strong> Alter S, Brinkman M, Kalra S, Nazif T, Parikh M, Kirtane AJ, et al. Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions. EuroIntervention. 2017; 13(12):e1468-e1474.<\/em><\/p>\n<p><em><strong>[13]<\/strong> Tomasello SD, Boukhris M, Jubilato S, Marza F, Garbo R, Contegiacomo G, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur, Heart, J. 2015; 36(45):3189-98.<\/em><br><em><strong>[14]<\/strong> Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017; 10(15):1523-34.<\/em><br><em><strong>[15]<\/strong> Gao L, Wang Y, Liu Y, Cao F, Chen Y. Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &#038; Interventions. 2017; 89(S1):574-81.<\/em><br><em><strong>[16]<\/strong> Cohen H.A., Williams D.O., Holmes D.R., et al. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: A report from the NHLBI Dynamic Registry. Am Heart J. 2003; 146(3):513-519<\/em><br><em><strong>[17]<\/strong> Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: The Canadian multicenter chronic total occlusions registry. J Am Lost Cardiol. 2012; 59(11):991-997.<\/em><br><em><strong>[18]<\/strong> Grantham JA, Marso SP, Spertus J, et al. Chronic Total Occlusion Angioplasty in the United States. JACC Cardiovasc Interv. 2009; 2(6):479-486.<\/em><br><em><strong>[19]<\/strong> Patel VG, Brayton KM, Tamayo A, et al. Angiographic Success and Procedural Complications in Patients Undergoing Percutaneous Coronary Chronic Total Occlusion Interventions. A Weighted Meta-Analysis of 18,061 Patients From 65 Studies. JACC Cardiovasc Interv. 2013; 6(2).<\/em><br><em><strong>[20]<\/strong> Christopoulos G, Menon RV, Karmpaliotis D, et al. Application of the \u201cHybrid Approach\u201d to Chronic Total Occlusions in Patients With Previous Coronary Artery Bypass Graft Surgery from a Contemporary Multicenter US Registry). Am J Cardiol. 2014;<\/em><br><em><strong>[21]<\/strong> Rathore S, Matsuo H, Terashima M, et al. Procedural and InHospital Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions of Coronary Arteries 2002 to 2008. Impact of Novel Guidewire Techniques. JACC Cardiovasc Interv. 2009; 2(6):489-497.<\/em><br><em><strong>[22]<\/strong> Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, et al; EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018; 39:2484\u20132493. doi:10.1093\/eurheartj\/ehy220<\/em><br><em><strong>[23]<\/strong> Schumacher SP, Stuijfzand WJ, de Winter RW, van Diemen PA, Bom MJ, Everaars H, et al. Ischemic burden reduction and long-term clinical outcomes after chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. (2021) 14:1407\u201318. doi: 10.1016\/j.jcin.2021.04.044<\/em><br><em>[24] Zhao S, Wang J, Chen Y, Wang W, Hu W, Zou Y, et al. Improvement of symptoms and quality of life after successful percutaneous coronary intervention for chronic total occlusion in elderly patients. J Am Heart Assoc. (2023) 12:e029034. doi: 10.1161\/JAHA.123.029034<\/em><br><em><strong><\/strong> Kucukseymen S, Iannaccone M, Grantham JA, Sapontis J, Juricic S, Ciardetti N, et al. Association of successful percutaneous revascularization of chronic total occlusions with quality of life: a systematic review and meta-analysis. JAMA Netw Open. (2023) 6:e2324522. doi: 10.1001\/jamanetworkopen.2023.24522<\/em><br><em>[26] Megaly M, Brilakis ES, Abdelsalam M, Pershad A, Saad M, Garcia S, et al. Impact of chronic total occlusion revascularization on left ventricular function assessed by cardiac magnetic resonance. JACC Cardiovasc Imaging. (2021) 14:1076\u20138. doi:10.1016\/j.jcmg.2020.10.012<\/em><br><em><strong>[27]<\/strong> Galassi AR, Brilakis ES, Boukhris M, Tomasello SD, Sianos G, Karmpaliotis D, et al. Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview. Heart J. (2015) 37:2692\u2013700. doi: 10.1093\/eurheartj\/ehv391<\/em><br><em><strong>[28]<\/strong> Watanabe H, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, et al. Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDO-Kyoto AMI registry). EuroIntervention. (2017) 12:e1874\u201382. doi: 10.4244\/EIJ-D-15-00421<\/em><br><em><strong>[29]<\/strong> Lindsey Cilia, Michael Megaly, Michael Megaly, Rhian Davies Rhian, Davies Behnam N. Tehrani Behnam N. Tehrani,. Truesdell, Alexander G. Truesdel; A non-interventional cardiologist&#8217;s guide to coronary chronic total occlusions; Virginia Heart, Falls Church, VA, United State<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b84e77e e-flex e-con-boxed e-con e-parent\" data-id=\"b84e77e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-6910637 e-flex e-con-boxed e-con e-child\" data-id=\"6910637\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-338ce06 e-flex e-con-boxed e-con e-child\" data-id=\"338ce06\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-4148d83 e-con-full e-flex e-con e-child\" data-id=\"4148d83\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7f33481 elementor-widget elementor-widget-heading\" data-id=\"7f33481\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Products<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-59011ac e-con-full elementor-hidden-mobile e-flex e-con e-child\" data-id=\"59011ac\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-51d5c8e e-flex e-con-boxed e-con e-child\" data-id=\"51d5c8e\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-37b0a47 e-flex e-con-boxed e-con e-child\" data-id=\"37b0a47\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2a7c4cf e-flex e-con-boxed e-con e-child\" data-id=\"2a7c4cf\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e620739 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"e620739\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/quiremspheres%E2%84%A2-microspheres\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/9-1-qllqn8feypy0pkqspzwyr7037ymnhac5rr4ewqtidg.webp\" title=\"9\" alt=\"9\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/quiremspheres%E2%84%A2-microspheres\" target=\"_blank\">QUIREM SPHERES<\/a><\/h3><p class=\"elementor-image-box-description\">TERUMO's Holmium platform is the first SIRT: comprehensive platform for the treatment of inoperable liver tumours. Quiremspheres\u2122: the only therapeutic SIRT microsphere used as part of a fully integrated platform<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b4069ba e-flex e-con-boxed e-con e-child\" data-id=\"b4069ba\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bc6ed07 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"bc6ed07\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/occlusafe%E2%84%A2-temporary-occlusion-balloon-microcatheter\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/10-qllqn2sdtpqarwyzmxh7c8fbnneg73prqz7i131ves.webp\" title=\"10\" alt=\"10\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/occlusafe%E2%84%A2-temporary-occlusion-balloon-microcatheter\" target=\"_blank\">OCCLUSAFE<\/a><\/h3><p class=\"elementor-image-box-description\">The occlusive balloon microcatheter from TERUMO allows redistribution of blood flow and micro-circulation, which increases the accumulation of therapeutic agents in the target lesion and reduces off-target embolization.<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ca678f8 e-flex e-con-boxed e-con e-child\" data-id=\"ca678f8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-53cbc84 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"53cbc84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/progreat%E2%84%A2-micro-catheter-system\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/Untitled-design-8-qllqmy36vjjv5v5tedg2hrm0oq1m4m742by2mp8u9w.webp\" title=\"Untitled design\" alt=\"Untitled design\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/progreat%E2%84%A2-micro-catheter-system\" target=\"_blank\">PROGREAT <\/a><\/h3><p class=\"elementor-image-box-description\">TERUMO microcatheter with integrated wire for therapeutic embolization and angiography in peripheral blood vessels. Ease of use, bend resistance, distal flexibility<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-573d9d9 e-flex e-con-boxed e-con e-child\" data-id=\"573d9d9\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-027bb00 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"027bb00\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/angio-seal%E2%84%A2-vip-vascular-closure-device\" target=\"_blank\" tabindex=\"-1\"><img decoding=\"async\" src=\"https:\/\/ambercell.eu\/wp-content\/uploads\/elementor\/thumbs\/Untitled-design-1-6-qllqmubu47epvfba0btk7sk6b6k59ts6ptc4pleeys.webp\" title=\"Untitled design (1)\" alt=\"Untitled design (1)\" loading=\"lazy\" \/><\/a><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\"><a href=\"https:\/\/www.terumo-europe.com\/en-emea\/products\/angio-seal%E2%84%A2-vip-vascular-closure-device\" target=\"_blank\">ANGIO SEAL VIP<\/a><\/h3><p class=\"elementor-image-box-description\">Angio-Seal\u2122 VIP Cruciate Vein Closure Device for closure and reduction of time to haemostasis at the site of common femoral artery puncture in patients undergoing diagnostic angiography or interventional procedures<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a97adac elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"a97adac\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4c2f91 elementor-widget elementor-widget-button\" data-id=\"c4c2f91\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/ambercell.eu\/en\/products\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-long-arrow-alt-right\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M313.941 216H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12h301.941v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.569 0-33.941l-86.059-86.059c-15.119-15.119-40.971-4.411-40.971 16.971V216z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">All products<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-872ea83 e-flex e-con-boxed e-con e-parent\" data-id=\"872ea83\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Percutaneous Coronary Intervention (PCI) is a minimally invasive coronary artery procedure designed to open narrowed or blocked coronary arteries that supply blood to the heart. It is most often performed on patients with ischemic heart disease or those who have suffered a myocardial infarction.<\/p>\n","protected":false},"author":5,"featured_media":10624,"parent":4601,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10417","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Selective intra-articular radiotherapy | AmberCell<\/title>\n<meta name=\"description\" content=\"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Selective intra-articular radiotherapy | AmberCell\" \/>\n<meta property=\"og:description\" content=\"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Ambercell\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-12T11:35:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1004\" \/>\n\t<meta property=\"og:image:height\" content=\"795\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/\",\"name\":\"Selective intra-articular radiotherapy | AmberCell\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"datePublished\":\"2025-04-09T07:19:58+00:00\",\"dateModified\":\"2026-11-12T11:35:55+00:00\",\"description\":\"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"contentUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp\",\"width\":1004,\"height\":795},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/selective-intra-arterial-radio-therapy-sirt-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For doctors\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cardiovascular diseases\",\"item\":\"https:\\\/\\\/ambercell.eu\\\/en\\\/for-doctors\\\/cardiovascular-diseases\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Percutaneous Coronary Intervention (CTO PCI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#website\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/\",\"name\":\"Ambercell\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ambercell.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#organization\",\"name\":\"Ambercell\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Ambercell-LOGO-@2x.webp\",\"contentUrl\":\"https:\\\/\\\/ambercell.eu\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Ambercell-LOGO-@2x.webp\",\"width\":438,\"height\":164,\"caption\":\"Ambercell\"},\"image\":{\"@id\":\"https:\\\/\\\/ambercell.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Selective intra-articular radiotherapy | AmberCell","description":"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/","og_locale":"en_US","og_type":"article","og_title":"Selective intra-articular radiotherapy | AmberCell","og_description":"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.","og_url":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/","og_site_name":"Ambercell","article_modified_time":"2026-11-12T11:35:55+00:00","og_image":[{"width":1004,"height":795,"url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/","url":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/","name":"Selective intra-articular radiotherapy | AmberCell","isPartOf":{"@id":"https:\/\/ambercell.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/#primaryimage"},"image":{"@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","datePublished":"2025-04-09T07:19:58+00:00","dateModified":"2026-11-12T11:35:55+00:00","description":"Innovative selective intra-arterial radio therapy for the treatment of HCC and mCRC tumors. Radioembolization, SIRT procedures for the diagnostic and treatment stages of liver cancer.","breadcrumb":{"@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/#primaryimage","url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","contentUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2025\/04\/whUL0SDKS9kDVHxJQGo32LLl1A0NyVOWgYFf6VrN.webp","width":1004,"height":795},{"@type":"BreadcrumbList","@id":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/selective-intra-arterial-radio-therapy-sirt-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ambercell.eu\/"},{"@type":"ListItem","position":2,"name":"For doctors","item":"https:\/\/ambercell.eu\/en\/for-doctors\/"},{"@type":"ListItem","position":3,"name":"Cardiovascular diseases","item":"https:\/\/ambercell.eu\/en\/for-doctors\/cardiovascular-diseases\/"},{"@type":"ListItem","position":4,"name":"Percutaneous Coronary Intervention (CTO PCI)"}]},{"@type":"WebSite","@id":"https:\/\/ambercell.eu\/#website","url":"https:\/\/ambercell.eu\/","name":"Ambercell","description":"","publisher":{"@id":"https:\/\/ambercell.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ambercell.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ambercell.eu\/#organization","name":"Ambercell","url":"https:\/\/ambercell.eu\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ambercell.eu\/#\/schema\/logo\/image\/","url":"https:\/\/ambercell.eu\/wp-content\/uploads\/2023\/11\/Ambercell-LOGO-@2x.webp","contentUrl":"https:\/\/ambercell.eu\/wp-content\/uploads\/2023\/11\/Ambercell-LOGO-@2x.webp","width":438,"height":164,"caption":"Ambercell"},"image":{"@id":"https:\/\/ambercell.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/pages\/10417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/comments?post=10417"}],"version-history":[{"count":4,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/pages\/10417\/revisions"}],"predecessor-version":[{"id":12568,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/pages\/10417\/revisions\/12568"}],"up":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/pages\/4601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/media\/10624"}],"wp:attachment":[{"href":"https:\/\/ambercell.eu\/en\/wp-json\/wp\/v2\/media?parent=10417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}